Georges Nseir is a Cardiology physician. OpenAlex indexes 10 publications with 457 citations (h-index 3).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
77 S Dobson Rd
Chandler, AZ 852246105
Telephone
480-814-0266Registry record last updated 20 Mar 2015.
Industry payments
42 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Boston Scientific CorporationProgram year202514 payments
- Endologix LLCProgram year202512 payments
- HEARTFLOW, INC.Program year20256 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
72.2%Beta blocker19.9%Metoprolol Tartrate34%Carvedilol31%Metoprolol Succinate28%Atenolol4%Propranolol Hcl2%Nebivolol Hcl2%Part D<11 patientsStatin17.8%Atorvastatin Calcium82%Rosuvastatin Calcium11%Pravastatin Sodium4%Simvastatin3%Part D<11 patients+ 15 more classes in this area
Blood & clotting
24.5%P2Y12 inhibitor16.5%Clopidogrel92%Brilinta8%Part D≥188 patientsFactor Xa inhibitor7.2%Eliquis81%Xarelto19%Part D≥49 patients+ 1 more class in this area
Metabolism & gastrointestinal
3.4%Potassium supplement1.2%Potassium Chloride100%Part D≥14 patientsProton pump inhibitor1.1%Pantoprazole Sodium100%Part D<11 patients+ 2 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Safety and Effectiveness of the Santreva™-ATK Endovascular Revascularization Catheter in the RESTOR-1 Peripheral CTO Crossing Pivotal Study
The American Journal of Cardiology
2026 - Coronary Flow Reserve Assessment of Orbital Atherectomy: An Observational Pilot Study
Journal of Biomedical Science and Engineering
2019 - Cangrelor With and Without Glycoprotein IIb/IIIa Inhibitors in Patients Undergoing Percutaneous Coronary Intervention
Journal of the American College of Cardiology
2017 - Pivotal Trial to Evaluate the Safety and Efficacy of the Orbital Atherectomy System in Treating De Novo, Severely Calcified Coronary Lesions (ORBIT II)
JACC: Cardiovascular Interventions
2014 - Des communautés et des sports au Liban : enjeux des regroupements sportifs et des rencontres intercommunautaires2012
Similar KOLs
Other experts from the same institution or the same specialty.
No other directory profiles share this institution yet.
Deepak Bhatt, MD
Icahn School of Medicine at Mount Sinai
Harlan Krumholz, MD
Yale School of Medicine
Scott Solomon, MD
Brigham and Women's Hospital
Eric Topol, MD
Scripps Research Institute (Scripps Research)
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”